136 related articles for article (PubMed ID: 28981730)
1. Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma of the bone.
Sakumoto M; Takahashi M; Oyama R; Takai Y; Kito F; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
Jpn J Clin Oncol; 2017 Oct; 47(10):954-961. PubMed ID: 28981730
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of patient-derived xenograft and its cell line of primary leiomyosarcoma of bone.
Oyama R; Takahashi M; Kito F; Sakumoto M; Shiozawa K; Qiao Z; Yoshida A; Endo M; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Jun; 54(6):458-467. PubMed ID: 29845452
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of NCC-LMS2-C1-a novel patient-derived cancer cell line of leiomyosarcoma.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2021 Jan; 34(1):279-288. PubMed ID: 33001379
[TBL] [Abstract][Full Text] [Related]
5. Establishment and proteomic characterization of a novel cell line, NCC-UPS2-C1, derived from a patient with undifferentiated pleomorphic sarcoma.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):257-263. PubMed ID: 29359268
[TBL] [Abstract][Full Text] [Related]
6. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.
Oyama R; Kito F; Takahashi M; Sakumoto M; Shiozawa K; Qiao Z; Noguchi R; Kubo T; Toki S; Nakatani F; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):202-213. PubMed ID: 30737713
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone.
Ono T; Noguchi R; Yoshimatsu Y; Sin Y; Tsuchiya R; Akiyama T; Kojima N; Toda Y; Sato C; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2023 Sep; 36(5):1804-1812. PubMed ID: 37328637
[TBL] [Abstract][Full Text] [Related]
9. Copper ions are novel therapeutic agents for uterine leiomyosarcoma.
Kakuda M; Matsuzaki S; Ueda Y; Shiomi M; Matsuzaki S; Kimura T; Fujita M; Egawa-Takata T; Kobayashi E; Serada S; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2020 Jan; 222(1):64.e1-64.e16. PubMed ID: 31351063
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone.
Ono T; Noguchi R; Yoshimatsu Y; Tsuchiya R; Sin Y; Nakagawa R; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2022 Jan; 35(1):392-399. PubMed ID: 34731453
[TBL] [Abstract][Full Text] [Related]
11. Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1.
Oyama R; Kito F; Sakumoto M; Shiozawa K; Toki S; Endo M; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 May; 54(5):392-399. PubMed ID: 29626278
[TBL] [Abstract][Full Text] [Related]
12. Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line.
Maekawa A; Kohashi K; Setsu N; Kuda M; Iura K; Ishii T; Matsunobu T; Nakatsura T; Iwamoto Y; Oda Y
Cancer Sci; 2016 Jan; 107(1):95-102. PubMed ID: 26560505
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of NCC-GCTB1-C1: a novel patient-derived cancer cell line of giant cell tumor of bone.
Noguchi R; Yoshimatsu Y; Ono T; Sei A; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
Hum Cell; 2020 Oct; 33(4):1321-1328. PubMed ID: 32815117
[TBL] [Abstract][Full Text] [Related]
14. Targeting TJP1 attenuates cell-cell aggregation and modulates chemosensitivity against doxorubicin in leiomyosarcoma.
Lee EY; Yu JY; Paek AR; Lee SH; Jang H; Cho SY; Kim JH; Kang HG; Yun T; Oh SE; Park SY; You HJ
J Mol Med (Berl); 2020 May; 98(5):761-773. PubMed ID: 32318747
[TBL] [Abstract][Full Text] [Related]
15. A role for versican in the development of leiomyosarcoma.
Keire PA; Bressler SL; Lemire JM; Edris B; Rubin BP; Rahmani M; McManus BM; van de Rijn M; Wight TN
J Biol Chem; 2014 Dec; 289(49):34089-103. PubMed ID: 25320080
[TBL] [Abstract][Full Text] [Related]
16. Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.
Mills AM; Beck AH; Montgomery KD; Zhu SX; Espinosa I; Lee CH; Subramanian S; Fletcher CD; van de Rijn M; West RB
Am J Surg Pathol; 2011 Apr; 35(4):583-9. PubMed ID: 21412072
[TBL] [Abstract][Full Text] [Related]
17. Integrated histologic and molecular analysis of uterine leiomyosarcoma and 2 benign variants with nuclear atypia.
Gao T; Finkelman BS; Ban Y; Li Y; Yin P; Bulun SE; Lu X; Ha C; Wei JJ
Cancer Sci; 2021 May; 112(5):2046-2059. PubMed ID: 33338329
[TBL] [Abstract][Full Text] [Related]
18. Uterine leiomyosarcoma and endometrial stromal sarcoma have unique miRNA signatures.
Ravid Y; Formanski M; Smith Y; Reich R; Davidson B
Gynecol Oncol; 2016 Mar; 140(3):512-7. PubMed ID: 26768834
[TBL] [Abstract][Full Text] [Related]
19. Primary bone leiomyosarcoma of distal femur: case report and literature review.
Georgeanu VA; Pletosu RI; Vlădescu TC; Bondari S; Crăciunescu A; Russu OM
Rom J Morphol Embryol; 2022; 63(3):569-574. PubMed ID: 36588496
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Modeling of Leiomyosarcoma Identifies Susceptibility to Transcriptional CDK Inhibitors through Antagonism of E2F-Driven Oncogenic Gene Expression.
Hemming ML; Bhola P; Loycano MA; Anderson JA; Taddei ML; Doyle LA; Lavrova E; Andersen JL; Klega KS; Benson MR; Crompton BD; Raut CP; George S; Letai A; Demetri GD; Sicinska E
Clin Cancer Res; 2022 Jun; 28(11):2397-2408. PubMed ID: 35325095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
